Boston, MA – Instem has announced the appointment of Szczepan Baran as Chief Scientific Officer. About Instem: Instem is a leading supplier of SaaS platforms across Discovery, Study Management, Regulatory Submission, and Clinical Trial Analytics. Its applications are utilized by customers worldwide to address the rapidly expanding needs of life science and healthcare organizations for data-driven decision-making, resulting in safer and more effective products. Founded in the United Kingdom in 1969, Instem has established deep international roots across North America, EMEA, and APAC regions. The company maintains a strong commercial and technical presence throughout these areas, providing localized support to its diverse client base. Instem has been an ARCHIMED company since 2023, and it recently appointed Szczepan Baran, VMD, MS, former Head of Emerging Technologies at Novartis, as Chief Scientific Officer to spearhead its scientific and AI strategy.

For more information on Instem please visit: https://www.instem.com/

Instem
800 Boylston St
Boston, MA 2199
Phone: 44 (0) 1785825600
LinkedIn Page: https://www.linkedin.com/company/instem/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved